Resources from the same session
Welcome & Introduction
Presenter: David Planchard
Session: Janssen-Cilag International NV - Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Resources:
Webcast
Updates in precision approaches to the molecular diagnosis of NSCLC
Presenter: Paul Hofman
Session: Janssen-Cilag International NV - Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Resources:
Webcast
Discussion: How can we address diagnostic challenges of NSCLC in clinical practice?
Presenter: Paul Hofman
Session: Janssen-Cilag International NV - Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Resources:
Webcast
New and emerging therapies for EGFR-mutant NSCLC
Presenter: Anne-Marie Dingemans
Session: Janssen-Cilag International NV - Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Resources:
Webcast
Discussion: What does the future hold for the management of EGFR-mutant NSCLC?
Presenter: Paul Hofman
Session: Janssen-Cilag International NV - Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Resources:
Webcast
Emerging treatment options for EGFR exon 20 insertions
Presenter: Sanjay Popat
Session: Janssen-Cilag International NV - Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Resources:
Webcast
Key learnings and closing remarks
Presenter: Maria Rosario Garcia Campelo
Session: Janssen-Cilag International NV - Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Resources:
Webcast